We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Risk Aversion Keeping New Drugs Off the Market, EMA Officials Warn
Risk Aversion Keeping New Drugs Off the Market, EMA Officials Warn
Today’s regulatory culture is too risk-averse when it comes to drug approvals and risks keeping promising treatments off the market, senior officials at the European Medicines Agency say.